tiprankstipranks
Advertisement
Advertisement
Idexx Laboratories raises FY26 EPS view to $14.45-$14.90 from $14.29-$14.80
PremiumThe FlyIdexx Laboratories raises FY26 EPS view to $14.45-$14.90 from $14.29-$14.80
12d ago
IDXX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
IDXX Upcoming Earnings Report: What to Expect?
15d ago
Idexx Laboratories price target lowered to $640 from $730 at UBS
Premium
The Fly
Idexx Laboratories price target lowered to $640 from $730 at UBS
19d ago
Idexx Laboratories management to meet with Piper Sandler
PremiumThe FlyIdexx Laboratories management to meet with Piper Sandler
2M ago
Idexx Laboratories Announces Executive Departure Amid Strategic Realignment
Premium
Company Announcements
Idexx Laboratories Announces Executive Departure Amid Strategic Realignment
2M ago
Top Hedge Fund Manager Sounds the Alarm on Market Risk. Here Are 4 Ways to Play a Possible Selloff
Premium
Market News
Top Hedge Fund Manager Sounds the Alarm on Market Risk. Here Are 4 Ways to Play a Possible Selloff
2M ago
Idexx Laboratories price target lowered to $730 from $750 at UBS
PremiumThe FlyIdexx Laboratories price target lowered to $730 from $750 at UBS
3M ago
Balanced Risk Profile and Slower Near-Term Margin Expansion Support Neutral Stance on Idexx Laboratories
Premium
Ratings
Balanced Risk Profile and Slower Near-Term Margin Expansion Support Neutral Stance on Idexx Laboratories
3M ago
Idexx Laboratories: Strong Q4 Execution, Robust 2026 Outlook, and Expanding Diagnostics Platform Support Buy Rating
Premium
Ratings
Idexx Laboratories: Strong Q4 Execution, Robust 2026 Outlook, and Expanding Diagnostics Platform Support Buy Rating
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100